Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 5 for:    anchor amc
Previous Study | Return to List | Next Study

Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions (ANCHOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02135419
Recruitment Status : Recruiting
First Posted : May 12, 2014
Last Update Posted : June 10, 2019
Sponsor:
Collaborators:
National Cancer Institute (NCI)
The Emmes Company, LLC
University of Arkansas
University of California, San Francisco
Information provided by (Responsible Party):
AIDS Malignancy Consortium

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 30, 2022
  Estimated Study Completion Date : June 30, 2022